While prolonged fasting increases the production and release of FGF21 to stimulate gluconeogenesis [49], a number of studies have shown that FGF21 administration in animals with obesity or diabetes effectively improves insulin sensitivity and glucose metabolism [50,51]. This evidence concerns the gene FGF21 and obesity disorder.